David Marin

Response to Imatinib Mesylate in Patients with Chronic Myeloproliferative Diseases with Rearrangements of the Platelet-Derived Growth Factor Receptor Beta

Jane F. Apperley, Martine Gardembas, Junia V. Melo et al. · New England Journal of Medicine · 2002 · 630 citations · Full text

Leukemia-induced phenotypic and functional defects in natural killer cells predict failure to achieve remission in acute myeloid leukemia

Kate Stringaris, Takuya Sekine, A. Khoder et al. · Haematologica · 2014 · 231 citations · Full text

Mixed-phenotype Acute Leukemia, Innate Immune System, Immunology +20

BCR-ABL1 compound mutations in tyrosine kinase inhibitor–resistant CML: frequency and clonal relationships

Jamshid S. Khorashad, Todd W. Kelley, Philippe Szankasi et al. · Blood · 2012 · 218 citations · Full text

Bone marrow mesenchymal stromal cells non-selectively protect chronic myeloid leukemia cells from imatinib-induced apoptosis via the CXCR4/CXCL12 axis

Fabrizio Vianello, Federica Villanova, Veronica Tisato et al. · Haematologica · 2010 · 167 citations · Full text

Allogeneic BK Virus–Specific T Cells for Progressive Multifocal Leukoencephalopathy

Muharrem Müftüoğlu, Amanda Olson, David Marin et al. · New England Journal of Medicine · 2018 · 165 citations · Full text

Immunology, Pathology, Immunotherapy +18